These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27431260)

  • 1. Effects of active bufadienolide compounds on human cancer cells and CD4+CD25+Foxp3+ regulatory T cells in mitogen-activated human peripheral blood mononuclear cells.
    Yuan B; He J; Kisoh K; Hayashi H; Tanaka S; Si N; Zhao HY; Hirano T; Bian B; Takagi N
    Oncol Rep; 2016 Sep; 36(3):1377-84. PubMed ID: 27431260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of regulatory T cells on the functioning of natural killer cells during cancer immunotherapy].
    Chikileva IO; Shubina IZh; Kiselevskiĭ MV
    Vestn Ross Akad Med Nauk; 2012; (4):60-4. PubMed ID: 22834330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
    Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
    Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of arsenic disulfide on proliferation, cytokine production, and frequencies of CD4(+), CD8(+), and regulatory T cells in mitogen-activated human peripheral blood mononuclear cells.
    Song MM; Fang S; Tanaka S; Sugiyama K; Kiyomi A; Kato R; Onda K; Yuan B; Takagi N; Hu X; Hirano T
    Int Immunopharmacol; 2015 Dec; 29(2):832-838. PubMed ID: 26359544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of anticancer agents on cell survival, proliferation, and CD4+CD25+Foxp3+ regulatory T cell-frequency in human peripheral-blood mononuclear cells activated by T cell-mitogen.
    Tohyama N; Tanaka S; Onda K; Sugiyama K; Hirano T
    Int Immunopharmacol; 2013 Jan; 15(1):160-6. PubMed ID: 23178575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
    Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
    Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cells.
    Mor A; Keren G; Kloog Y; George J
    Eur J Immunol; 2008 Jun; 38(6):1493-502. PubMed ID: 18461565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone upregulates FOXP3 expression without increasing regulatory activity.
    Prado C; Gómez J; López P; de Paz B; Gutiérrez C; Suárez A
    Immunobiology; 2011 Mar; 216(3):386-92. PubMed ID: 20667622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytocidal effects of arenobufagin and hellebrigenin, two active bufadienolide compounds, against human glioblastoma cell line U-87.
    Han L; Yuan B; Shimada R; Hayashi H; Si N; Zhao HY; Bian B; Takagi N
    Int J Oncol; 2018 Dec; 53(6):2488-2502. PubMed ID: 30272276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels.
    Zhao J; Cao Y; Lei Z; Yang Z; Zhang B; Huang B
    Cancer Res; 2010 Jun; 70(12):4850-8. PubMed ID: 20501849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
    Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
    Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4+CD25+Treg cells.
    Wang B; Li B; Dai Z; Ren S; Bai M; Wang Z; Li Z; Lin S; Wang Z; Huang N; Yang P; Liu M; Min W; Ma H
    Int J Biochem Cell Biol; 2014 Oct; 55():98-108. PubMed ID: 25168696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
    Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
    Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
    Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
    Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of circulating allergen-specific CD4+CD25highFoxp3+ T-regulatory cells in both nonatopic and atopic individuals.
    Maggi L; Santarlasci V; Liotta F; Frosali F; Angeli R; Cosmi L; Maggi E; Romagnani S; Annunziato F
    J Allergy Clin Immunol; 2007 Aug; 120(2):429-36. PubMed ID: 17604089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells.
    Khan S; Burt DJ; Ralph C; Thistlethwaite FC; Hawkins RE; Elkord E
    Clin Immunol; 2011 Jan; 138(1):85-96. PubMed ID: 21056008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
    Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
    Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vitamin K3 and K5 on proliferation, cytokine production, and regulatory T cell-frequency in human peripheral-blood mononuclear cells.
    Hatanaka H; Ishizawa H; Nakamura Y; Tadokoro H; Tanaka S; Onda K; Sugiyama K; Hirano T
    Life Sci; 2014 Mar; 99(1-2):61-8. PubMed ID: 24503338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
    Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
    Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.